[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1604492A - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
AU1604492A
AU1604492A AU16044/92A AU1604492A AU1604492A AU 1604492 A AU1604492 A AU 1604492A AU 16044/92 A AU16044/92 A AU 16044/92A AU 1604492 A AU1604492 A AU 1604492A AU 1604492 A AU1604492 A AU 1604492A
Authority
AU
Australia
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16044/92A
Inventor
Gerd Bartoszyk
Henning Bottcher
Klaus-Otto Minck
Christoph Seyfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU1604492A publication Critical patent/AU1604492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU16044/92A 1991-05-10 1992-05-05 Indole derivatives Abandoned AU1604492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4115215 1991-05-10
DE4115215A DE4115215A1 (en) 1991-05-10 1991-05-10 INDOLDER DERIVATIVES

Publications (1)

Publication Number Publication Date
AU1604492A true AU1604492A (en) 1992-11-12

Family

ID=6431344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16044/92A Abandoned AU1604492A (en) 1991-05-10 1992-05-05 Indole derivatives

Country Status (14)

Country Link
EP (1) EP0512350A3 (en)
JP (1) JPH05155886A (en)
KR (1) KR920021507A (en)
AU (1) AU1604492A (en)
CA (1) CA2068238A1 (en)
CS (1) CS130592A3 (en)
DE (1) DE4115215A1 (en)
HU (1) HU208136B (en)
IE (1) IE921488A1 (en)
MX (1) MX9202152A (en)
NO (1) NO921831L (en)
PL (1) PL294457A2 (en)
TW (1) TW221807B (en)
ZA (1) ZA923351B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342845A (en) * 1990-08-31 1994-08-30 Nippon Shinyaku Company Limited Indole derivatives and drugs
IT1255467B (en) * 1992-07-29 1995-11-02 Dompe Farmaceutici Spa PHARMACOLOGICALLY ACTIVE ACRYLIC STARCHES
WO2002016358A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
AU2001282875A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
DE10045112A1 (en) * 2000-09-11 2002-03-21 Merck Patent Gmbh Use of indole derivatives for the treatment of diseases of the central nervous system
AR036041A1 (en) 2001-06-12 2004-08-04 Upjohn Co HETEROCICLIC AROMATIC COMPOUNDS REPLACED WITH QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR036040A1 (en) 2001-06-12 2004-08-04 Upjohn Co MULTICICLIC HETEROARYL COMPOUNDS REPLACED WITH QUINUCLIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NZ531786A (en) 2001-10-02 2006-10-27 Upjohn Co Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
DE10164139A1 (en) 2001-12-27 2003-07-10 Bayer Ag 2-heteroaryl carboxamides
BR0307735A (en) 2002-02-19 2005-01-25 Upjohn Co Fused Bicyclic N-Bridged Heteroaromatic Carboxamides for Disease Treatment
EP1476448A2 (en) 2002-02-19 2004-11-17 PHARMACIA & UPJOHN COMPANY Azabicyclic compounds for the treatment of disease
AU2003253686A1 (en) 2002-08-01 2004-02-23 Pharmacia & Upjohn Company Llc 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
WO2009158375A1 (en) * 2008-06-25 2009-12-30 Abbott Laboratories Aza-cylic indole- 2 -carboxamides and methods of use thereof
CA2744278C (en) 2008-11-19 2015-09-08 Envivo Pharmaceuticals, Inc. Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
SG185594A1 (en) 2010-05-17 2012-12-28 Envivo Pharmaceuticals Inc A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
US9585877B2 (en) 2012-05-08 2017-03-07 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
DE3881950T2 (en) * 1987-04-25 1993-09-30 Beecham Group Plc Azabicyclic compounds, processes for their preparation and pharmaceutical preparations containing them.
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DE3810552A1 (en) * 1988-03-29 1989-10-19 Sandoz Ag Esters and amides of indole-, benzo[b]thiophene or benzo[b]furancarboxylic acids or 4-amino-2-methoxybenzoic acids with N-heterocyclic or N-heterobicyclic alcohols or amines, processes for their preparation, pharmaceutical compositions containing them and applicator for administration thereof

Also Published As

Publication number Publication date
HU208136B (en) 1993-08-30
KR920021507A (en) 1992-12-18
EP0512350A3 (en) 1992-12-16
HU9201550D0 (en) 1992-07-28
EP0512350A2 (en) 1992-11-11
CA2068238A1 (en) 1992-11-11
TW221807B (en) 1994-03-21
DE4115215A1 (en) 1992-11-12
HUT61541A (en) 1993-01-28
IE921488A1 (en) 1992-11-18
NO921831L (en) 1992-11-11
NO921831D0 (en) 1992-05-08
JPH05155886A (en) 1993-06-22
CS130592A3 (en) 1992-11-18
MX9202152A (en) 1992-11-01
ZA923351B (en) 1993-01-27
PL294457A2 (en) 1992-11-16

Similar Documents

Publication Publication Date Title
AU3692393A (en) Indole derivatives
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU3349893A (en) Indole derivatives
AU4271193A (en) Indole derivative
AU6666990A (en) Indole derivatives
AU2706292A (en) Heterobiaryl derivatives
AU1655192A (en) Antivizal dibenzothiazepinone derivatives
IL105206A0 (en) Indole derivatives
AU1604492A (en) Indole derivatives
GB9326332D0 (en) Indole derivatives
AP9400685A0 (en) Indole derivatives
GB9319297D0 (en) Indole derivatives
AP9400633A0 (en) Indole derivatives
AU2327192A (en) Indoles
GB9116732D0 (en) Indole derivatives
AU1033992A (en) 3-quinuclidine derivatives
AU2686592A (en) Tetraphenylporphyn derivatives
GB9204024D0 (en) Indole derivatives
AU1153892A (en) Pyrimidinyl- and triazinylsalicyl- and -picolinylaldehyde derivatives
AU644451B2 (en) Indole derivative
GB9302577D0 (en) Indole derivatives
GB9105592D0 (en) Indole derivatives
HRP921448A2 (en) Indole derivatives
GB9206794D0 (en) Indole derivatives
GB9206810D0 (en) Indole derivatives